Popular stocks:

Rivian Automotive

TOP stocks:

Shares of other companies:

Greenidge Generation Holdings

Signature Bank

IBM

China Evergrande New Energy Vehicle Group

Just Eat Takeaway.com

Fulcrum Therapeutics (FULC) stock forecast for 2024

Last update: 05-19-2022, 12:52

Sector: Healthcare

The share price of Fulcrum Therapeutics, Inc. (FULC) now

What analysts predict:: $32.75

52-week high/low: $33.1 / $6.85

50/200 Day Moving Average: $14.85 / $17.86

This figure corresponds to the average price over the previous 50/200 days. For Fulcrum Therapeutics stocks, the 50-day moving average is the resistance level today.

For Fulcrum Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Fulcrum Therapeutics stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Fulcrum Therapeutics stock price in 2024. How much will one Fulcrum Therapeutics share be worth in 2024?

Is it worth taking profit / loss on Fulcrum Therapeutics stock now or waiting? What are analysts' forecasts for Fulcrum Therapeutics stock?

We forecast Fulcrum Therapeutics stock performance using neural networks based on historical data on Fulcrum Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

The Fulcrum Therapeutics stock prediction results are shown below and presented as a graph, table and text information.

Fulcrum Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Fulcrum Therapeutics analysts is $32.75.

Today 200 Day Moving Average is the resistance level (17.86 $).

50 Day Moving Average is the resistance level (14.85 $).

Historical and forecast chart of Fulcrum Therapeutics stock

The chart below shows the historical price of Fulcrum Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Fulcrum Therapeutics stock price can be found in the table below.

Subscribe to update forecasts!

Fulcrum Therapeutics (FULC) Forecast for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	13.88	12.58	15.13	16.88 %
Feb	14.82	12.63	15.89	20.52 %
Mar	15.98	13.58	16.88	19.51 %
Apr	15.41	14.76	17.75	16.84 %
May	14.88	13.39	16.10	16.82 %
Jun	16.07	14.82	17.74	16.49 %
Jul	16.49	14.35	18.47	22.32 %
Aug	15.80	13.65	17.60	22.44 %
Sep	14.50	13.89	15.29	9.11 %
Oct	11.72	10.26	12.28	16.41 %
Nov	10.36	8.91	11.02	19.17 %
Dec	10.30	9.06	11.76	22.94 %

Fulcrum Therapeutics information and performance

Fulcrum Therapeutics is a biopharmaceutical company that develops drugs to treat genetic diseases. The company has developed product candidates to modulate gene expression and potentially treat the underlying cause of these diseases.

Fulcrum Therapeutics Address

26 LANDSDOWNE STREET, CAMBRIDGE, MA, US

Market Capitalization: 357 013 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -67 074 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.286

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 0.197

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 9.75

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 40848200

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Fulcrum Therapeutics price target for 2021 by month

Target values for the price of one Fulcrum Therapeutics share for Jan 2024.

The weighted average target price per Fulcrum Therapeutics share in Jan 2024 is: 13.88. In Jan, the positive dynamics for Momo shares will prevail with possible monthly volatility of 16.881% volatility is expected.

Pessimistic target level: 12.58

Optimistic target level: 15.13

Target values for the price of one Fulcrum Therapeutics share for Feb 2024.

The weighted average target price per Fulcrum Therapeutics share in Feb 2024 is: 14.82. In Feb, the positive dynamics for Momo shares will prevail with possible monthly volatility of 20.522% volatility is expected.

Pessimistic target level: 12.63

Optimistic target level: 15.89

Target values for the price of one Fulcrum Therapeutics share for Mar 2024.

The weighted average target price per Fulcrum Therapeutics share in Mar 2024 is: 15.98. In Mar, the positive dynamics for Momo shares will prevail with possible monthly volatility of 19.508% volatility is expected.

Pessimistic target level: 13.58

Optimistic target level: 16.88

Target values for the price of one Fulcrum Therapeutics share for Apr 2024.

The weighted average target price per Fulcrum Therapeutics share in Apr 2024 is: 15.41. In Apr, the negative dynamics for Momo shares will prevail with possible monthly volatility of 16.841% volatility is expected.

Pessimistic target level: 14.76

Optimistic target level: 17.75

Target values for the price of one Fulcrum Therapeutics share for May 2024.

The weighted average target price per Fulcrum Therapeutics share in May 2024 is: 14.88. In May, the negative dynamics for Momo shares will prevail with possible monthly volatility of 16.821% volatility is expected.

Pessimistic target level: 13.39

Optimistic target level: 16.10

Target values for the price of one Fulcrum Therapeutics share for Jun 2024.

The weighted average target price per Fulcrum Therapeutics share in Jun 2024 is: 16.07. In Jun, the positive dynamics for Momo shares will prevail with possible monthly volatility of 16.485% volatility is expected.

Pessimistic target level: 14.82

Optimistic target level: 17.74

Target values for the price of one Fulcrum Therapeutics share for Jul 2024.

The weighted average target price per Fulcrum Therapeutics share in Jul 2024 is: 16.49. In Jul, the positive dynamics for Momo shares will prevail with possible monthly volatility of 22.322% volatility is expected.

Pessimistic target level: 14.35

Optimistic target level: 18.47

Target values for the price of one Fulcrum Therapeutics share for Aug 2024.

The weighted average target price per Fulcrum Therapeutics share in Aug 2024 is: 15.80. In Aug, the negative dynamics for Momo shares will prevail with possible monthly volatility of 22.441% volatility is expected.

Pessimistic target level: 13.65

Optimistic target level: 17.60

Target values for the price of one Fulcrum Therapeutics share for Sep 2024.

The weighted average target price per Fulcrum Therapeutics share in Sep 2024 is: 14.50. In Sep, the negative dynamics for Momo shares will prevail with possible monthly volatility of 9.108% volatility is expected.

Pessimistic target level: 13.89

Optimistic target level: 15.29

Target values for the price of one Fulcrum Therapeutics share for Oct 2024.

The weighted average target price per Fulcrum Therapeutics share in Oct 2024 is: 11.72. In Oct, the negative dynamics for Momo shares will prevail with possible monthly volatility of 16.412% volatility is expected.

Pessimistic target level: 10.26

Optimistic target level: 12.28

Target values for the price of one Fulcrum Therapeutics share for Nov 2024.

The weighted average target price per Fulcrum Therapeutics share in Nov 2024 is: 10.36. In Nov, the negative dynamics for Momo shares will prevail with possible monthly volatility of 19.173% volatility is expected.

Pessimistic target level: 8.91

Optimistic target level: 11.02

Target values for the price of one Fulcrum Therapeutics share for Dec 2024.

The weighted average target price per Fulcrum Therapeutics share in Dec 2024 is: 10.30. In Dec, the negative dynamics for Momo shares will prevail with possible monthly volatility of 22.942% volatility is expected.

Pessimistic target level: 9.06

Optimistic target level: 11.76

Related stocks from Healthcare sector

DaVita Inc. (DVA)

China Evergrande New Energy Vehicle Group Lim. (EVGRF)

Progenity, Inc. (PROG)

GoodRx Holdings, Inc. (GDRX)

Organon & Co. (OGN)

Koninklijke Philips N.V. (PHG)

Allarity Therapeutics, Inc. (ALLR)

DENTSPLY SIRONA Inc. (XRAY)

Nuvectis Pharma, Inc. (NVCT)

Berkeley Lights, Inc. (BLI)

All stock predictions

All currency forecasts

All cryptocurrency predictions

Detailed predictions for Fulcrum Therapeutics stock

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.